How to enable a genomic revolution without risking a data privacy catastrophe
Data security and compliance are recurring themes in the many conversations I have with researchers and organisations in life sciences.
I have had the opportunity to get to know a great many people in life sciences. Whether pharma, drug discovery, biotech, academia, or DTC companies, they all share the common goal of advancing medicine and improving life.
Genome-wide association studies (GWAS) have gained traction since the mid 2000s, with over 7,800 GWAS studies performed which have facilitated the detection of over 159,200 unique ‘needles’ – SNP-trait associations, all archived in EMBL-EBI’s GWAS Catalogue.